Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture ; volume:19 ; number:1 ; day:26 ; month:11 ; year:2019 ; pages:1-6 ; date:12.2019
BMC ophthalmology ; 19, Heft 1 (26.11.2019), 1-6, 12.2019
- Urheber
-
Barth, T.
Zeman, F.
Helbig, H.
Gamulescu, M.-A
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-019-1242-7
- URN
-
urn:nbn:de:101:1-2020032119282951159470
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barth, T.
- Zeman, F.
- Helbig, H.
- Gamulescu, M.-A
- SpringerLink (Online service)
Ähnliche Objekte (12)
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
Inflammasome activation aggravates choroidal neovascularization
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
Inflammasome activation aggravates choroidal neovascularization
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
Inflammasome activation aggravates choroidal neovascularization
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization